Horizon Pharma | HZNP - Gross Profit On Sales

Horizon Pharma reported $701.24M in Gross Profit on Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Gross Profit On Sales Change
ALKERMES ALKS:US USD 250.71M 48.98M
Amgen AMGN:US USD 5.09B 28M
AstraZeneca AZN:LN USD 8.7B 168M
Bristol Myers Squibb BMY:US USD 8.89B 21M
Cara Therapeutics CARA:US USD 1.13M 6.63M
Coherus Biosciences CHRS:US USD 31.15M 20.96M
Eli Lilly And LLY:US USD 5.75B 391.2M
Endo International Ordinary Shares ENDP:US USD 364.83M 28.49M
Horizon Pharma HZNP:US USD 701.24M 10.01M
JAZZ PHA JAZZ:US USD 804.76M 2.23M
Merk MRK:US USD 10.47B 610M
Novartis NOVN:VX USD 9.16B 21M
Pacira Pharmaceuticals PCRX:US USD 110.04M 6.75M
Perrigo Ordinary Shares PRGO:US USD 382.6M 19.7M
Pfizer PFE:US USD 14.47B 2.08B
Prestige Brands PBH:US USD 150.4M 10.61M
Revance Therapeutics RVNC:US USD 26.41M 8.13M
Supernus Pharmaceuticals SUPN:US USD 144.37M 7.1M
Takeda 4502:JP JPY 760.58B 63.72B
Teva Pharmaceutical Industries TEVA:US USD 2.1B 390M
Valeant Pharmaceuticals VRX:CN USD 1.54B 79M
Xeris Pharmaceuticals Inc XERS:US USD 26.85M 2.39M
Zoetis ZTS:US USD 1.39B 7M